MedTrace Logo

Reducing Hospital Readmissions in Patients With Depressive Symptoms

NCT01840826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 709

Last updated 2018-03-07

No results posted yet for this study

Summary

Project Re-Engineered Discharge (Project RED) has previously demonstrated that patients who received the RED were 30% less likely than patients receiving usual care to access inpatient or emergency services within 30 days of discharge. In this project, the investigators add a new dimension to RED by integrating screening, referral and treatment for depression into the original RED intervention and determining if this enhanced intervention increases the effectiveness of RED in preventing readmissions and controlling costs in the 180 days after discharge for patients with signs of depression.

Conditions

Interventions

OTHER

RED-D Care Management

The Case Management intervention will continue for 12 weeks post-discharge (from the index admission).

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Brian W Jack, MD · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01840826 on ClinicalTrials.gov